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Treatment options for trigeminal neuralgia (TN) must be customized for the individual patient, and physicians must be aware of
themedical,surgical,andradiationtreatment modalitiestoprescribeoptimaltreatmentcoursesforspeciﬁcpatients.Thefollowing
caseillustratesthepotentialforgammakniferadiosurgery(GKRS)toberepeated multipletimesforthepurpose ofachievingfacial
pain control in cases of TN that have been refractory to other medical and surgical options, as well as prior GKRS. The patient
described failed to achieve pain control with initial GKRS, as well as medical and surgical treatments, but experienced signiﬁcant
pain relief for a period of time with a second GKRS procedure and later underwent a third procedure. Only a small subset of
patients have reportedly undergone more than two GKRS for TN; thus, further research and long-term clinical followup will be
valuable in determining its usefulness in speciﬁc clinical situations.
1.Introduction
Trigeminal neuralgia (TN), also known as tic douloureux,i s
a disorder of the sensory nucleus of cranial nerve V, which
causes severe episodic shooting pains in one or more of its
three divisions (V1–V3). TN is most commonly idiopathic,
but may be caused by pressure from a structure, such as
a blood vessel compressing or pulsating on the trigeminal
nerve or its vasculature. This condition aﬀects females twice
as often as males, with a peak incidenceat 60 years of age [1].
Triggers for episodes of pain vary greatly among individuals,
with patients commonly reporting pain with brushing teeth,
chewing, talking, touching the face, and cold sensations on
the face or teeth. Options for management of TN include
medical, surgical, and radiation approaches. This paper
describes a rare and unique course of treatment for TN due
to the refractory nature of the disease process and because
thepatientreceived threeseparate gamma knife radiosurgery
(GKRS) treatments. This course of treatment may prove
useful in a selected group of patients with a similar clinical
situation.
2.Case Report
A 72-year-old man was referred to a community oncology
center by his neurologist due to complaints of a recurrence
of lancinating, “shock-like” pain in the left side of his face
from the preauricular area into the left side of his upper and
lower jaws. The patient stated that the pain was intermittent,
10/10 in intensity (on a scale of 1 to 10, with 10 being the
worst), and was triggered by several actions including eat-
ing, brushing gums, cold sensations, and touching his face.2 Case Reports in Medicine
The patient stated that the pain was accompanied by tender-
nessandsensitivity totoucharoundtheoutsidemarginofhis
lefteye,buthedeniednumbnessorotherchangeinsensation
in the aﬀected area.
Thepatientstatedthathissymptomsbeganasan“annoy-
ance” approximately 4.5 years prior and progressed slowly
overthecourseof thenext 3years, atwhich timehewas diag-
nosedwithTNbyhisdentist.AnMRIofthebrainperformed
at the time of diagnosis demonstrated a tortuous basilar
artery abutting the left trigeminal nerve. He was initially
started on Gabapentin, which provided only mild relief.
Carbamazepine was addedlater, butitcaused him tobecome
excessively drowsy, which resulted in a signiﬁcant fall and
concussion. Due to his fall, the medications were discontin-
ued.
Followingfailureofmedicalmanagement,thepatientwas
oﬀered further treatment options including microvascular
decompression (MVD), radiofrequency gangliotomy, and
GKRS. The patient elected to undergo GKRS which was per-
formedwithaLeksellmodelCgammaknifetothetrigeminal
nerve root entry zone with 201 cobalt sources (4mm shot
size) to a dose of 42Gy prescribed to the 50% isodose line
for a maximum point dose of 84Gy (see Figure 1). Shortly
after the procedure, the patient experienced mild relief of
pain but had a sudden recurrence in the second division of
the trigeminal nerve within 2 months. In hopes of achieving
further pain relief, the patient underwent a radiofrequency
gangliotomy procedure at a major university medical center
7m o n t h sa f t e rh i sG K R S ,w h i c hp r o v i d e dp a i nr e l i e ff o ra
period of4 months. However,the patient’spain recurred and
became debilitating leading him to again seek treatment. A
second GKRS procedure was performed 1 month after pain
recurrence (approximately 11 months after the ﬁrst one),
with the same proximal nerve root entry zone targeted to a
dose of 27Gy to the 50% isodose line for a maximum dose
of 54Gy at the center point. At that point, the patient had
a maximum dose of 138Gy to the nerve. Shortly after the
procedure, the patient experienced nearly complete resolu-
tion of his pain for the next 6.5 months and was able to
discontinue all oral pain medications. However, the patient
began to experience gradual recurrence of the pain in his left
upperand lowerjaws andagainsoughtevaluationforfurther
pain control.
Medical, surgical, and radiosurgical pain management
options were again discussed with the patient. He stated that
he would prefer to avoidsurgery and had diﬃculty tolerating
pain medications, which he reported made him feel drowsy
and disoriented. The patient stated that he would prefer to
havea3rdGKRSprocedurebecauseitwastheonlytreatment
that had provided him extended and signiﬁcant pain relief.
The patient underwent his 3rd GK treatment approximately
17monthsafterhisﬁrst one.The3rdtreatment wasdelivered
a few millimeters distal from the previous target and was
prescribed 20 Gy (with 4mm shots) to the 50% isodose
line (see Figure 2) for a maximum point dose of 40Gy. This
lower treatment dose and more distal target were chosen in
an attempt to limit neural toxicity from the already high
cumulative dose to the nerve. The 50% isodose line for the
third target was set on the nerve to match the 50% isodose
A
R
Figure 1: Axial section through the brainstem at the nerve root
entry zone of the left trigeminal nerve with an illustration of the
location of the 50% isodose line for gamma knife radiation treat-
mentplanning.Thiswasthetreatmentlocationfortheﬁrstandsec-
ond gamma knife procedures.
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Figure 2: Axial section through the brainstem at the nerve root
entry zone of the left trigeminal nerve with an illustration of the
location of the 50% isodose line for the gamma knife radiation
treatment planning. This was the location of treatment for his third
course of treatment.
line location for the previous two targets. Therefore, there
was some additional dose fall-oﬀ into the previously treated
region from the lower isodose regions.
The patient was symptom free and reported no side
eﬀects or focal neurological problems for 3 months after the
procedure. At that point, he experienced recurrence of his
painandunderwentamicrovasculardecompression(MVD).
At his 6 month followup from MVD, he reported having no
pain or facial numbness.Case Reports in Medicine 3
Since initial presentation, the patient has had regular
follow-up visits with his primary care physician, neurosur-
geon,and radiation oncologist.The patient’sreported lackof
facial numbness and other side eﬀects were veriﬁed through
follow-up physical examinations. He will continue to be
followed closely by his treating physicians in the future and
understands that with retreatment his risks of permanent
side eﬀects are increased.
3.Discussion
Optimal treatment of TN remains challenging, as each clin-
ical situation can vary signiﬁcantly. This case illustrates a
unique approach to the management of TN in that this
patient has received 3 separate GKRS treatments to the same
nerve root for refractory disease. Patients who suﬀer from
TN have a number of treatment modalities to consider, and
treatments should be tailored to the individual situation.
Medications in the form of anticonvulsants, such as Ga-
bapentin and Carbamazepine, as well as antidepressants, are
the predominant method for treating TN-related facial pain.
However, there is a fraction of patients who experience only
limited relief from pharmacotherapy or are unable to endure
the side eﬀects of the prescribed drugs and, thus, seek other
treatment alternatives [2].
Neurosurgical intervention is often the next line of treat-
ment for patients where pharmaceuticals have failed. Micro-
vasculardecompression(MVD)isaprocedurethatinvolvesa
craniotomy to locate and separate veins or arteries in contact
with the trigeminal nerve, while preserving its function
[3]. MVD has been proven to provide patients with TN
pain relief, but carries with it the risks of neurosurgical
complications which may not be acceptable for patients
with certaincomorbidities[4].Percutaneousrhizotomies are
another set of neurosurgical procedures that create a perma-
nent lesion at the trigeminal root or ganglion by thermal,
chemical, or mechanical means [3]. These procedures are
generally regarded as safe and eﬀective with low incidence
of unwanted side eﬀects [5] such as nerve damage [3, 4]a n d
vascular injury.
GKRS has been shown to be safe and eﬀective in patients
with medically [6] and surgically [7]r e f r a c t i v eT N .O n
an increasing number of occasions, GKRS is attempted a
second time and in only a handful of cases have outcomes
been reported in the literature where a 3rd treatment was
performed, making it largely uncharted territory. Repeat
GKRS, in cases where it has previously been eﬀective, have
reported similar rates of complete pain control as with the
initial procedure [8]. However, successful retreatment of
patientsinwhomtheinitial GKtreatment failsisalsofeasible
[9] ,a sw a si l l u s t r a t e di nt h i sc a s ew i t ht h es e c o n dG K R S .
Overall, repeat GKRS has been shown to provide signiﬁcant
pain relief in more than 2/3 of patients [10, 11], with some
studies showing similar [12, 13]a n do t h e r ss h o w i n gb e t t e r
[11] overall facial-pain outcomesthan primary radiosurgery.




ment modalities for idiopathic TN in patients who had un-
dergone three or more previous operations of any kind.
This study found that posterior fossa exploration resulted
in better facial pain outcomes than SRS or percutaneous
techniques in this group of patients; however, this paper
acknowledgesselection biasin theirchoiceoftreatment [16].
Based on the fact that the patient in this paper had at least
3 interventions for pain relief prior to his 3rd GKRS, the
Pollockstudywouldhavepredictedthathehada36%chance
of complete pain relief after 3 years and a 45% chance of new
facial numbness or dysesthetic pain. It should be noted that
the study did not mention whether any patient underwent
3G K R Sm a k i n gi td i ﬃcult to stratify the likely outcome.
Another study by Gellner et al. reported two patients, each
had four GKRS operations, but gave few details about those
speciﬁc cases or their outcomes [10].
Studies disagree about the incidence of complications in
primary versus repeat GKRS, with some showing no sig-
niﬁcant increase in incidence of complications beyond that
observed in the initial procedure [8], and others showing a
signiﬁcant diﬀerence for side eﬀects, such as facial numbness
[9, 11, 13, 17, 18]. Huang et al. suggested that the incidence
of facial numbness was signiﬁcantly increased above acumu-
lative dose of 115Gy [17, 19]. Dvorak et al. showed a dose-
response relationship forbothpain controland development
of side eﬀects, with doses above 130Gy more likely to result
in a new dysfunction, as well as improved pain control
[9]. Other studies have demonstrated the same correlation
between pain control and development of unwanted side
eﬀects[18–20]. Another study notes that at cumulativedoses
above 163Gy, the rate of bothersome numbness was in the
range of 16% [11]. In the presented case, an attempt was
made to reduce neural toxicity by lowering the 2nd and
3rd GKRS doses to maximum-point doses of 54 and 40Gy,
respectively. It was felt that repeating the initial dose of 42Gy
to the 50% isodose line (84Gy maximum) would too greatly
increase the patient’s likelihood of bothersome side eﬀects.
The radiosurgery target area may also play a signiﬁcant
role in both maximizing pain control and limiting side
eﬀects. Zhang et al. showed that increasing the isocenter
distance between the two radiosurgeries was associated with
improved pain relief, regardless of whether the second
isocenter was placed proximal or distal to the ﬁrst [21].
Although this study found no relationship between distance
between isocenters (in ﬁrst and second radiosurgeries) and
occurrence of dysesthesias, only ﬁve patients with dyses-
thesias were included in this segment of the study. Using
this premise, the treatment isocenter for the 3rd GKRS was
moveddistallyinhopesofachievingabetterclinicalresponse
while limiting side eﬀects.
4.Conclusion
This paper highlights a case of TN refractory to initial medi-
cal and surgical management, nonresponsive to an initial
GKRS procedure, responsive to second and third GKRS pro-
cedures, and having undergone an MVD due to refractory4 Case Reports in Medicine
painafterapain-freeinterval.Thisisoneofveryfewreported
casesofa patientundergoingthreeGKRSproceduresforTN.
Further research will be valuable in determining its useful-
ness in clinical practice.
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